# High-Resolution Microendoscopy to Guide Hysteroscopic Tumor Resection

> **NCT02095847** · PHASE2 · WITHDRAWN · sponsor: **M.D. Anderson Cancer Center**

## Conditions studied

- Uterine Cancer

## Interventions

- **PROCEDURE:** High-Resolution Microendoscopy Imaging
- **DRUG:** Proflavine

## Key facts

- **NCT ID:** NCT02095847
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2015-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02095847

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02095847, "High-Resolution Microendoscopy to Guide Hysteroscopic Tumor Resection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02095847. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*